A Phase I Study of TAS-102 in Solid Tumors

Clinical trial NCT02261532 · COMPLETED

Trial details

NCT number: NCT02261532
Sponsor: Taiho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors

Start date: 2014-09-01
Primary completion: 2015-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.